The Impact of Patient Support Programs on Adherence to Disease-Modifying Therapies of Patients with Relapsing-Remitting Multiple Sclerosis in Germany: A Non-Interventional, Prospective Study
Crossref DOI link: https://doi.org/10.1007/s12325-020-01349-3
Published Online: 2020-04-24
Published Print: 2020-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lenz, Florian
Harms, Lutz
Funding for this research was provided by:
Teva Pharmaceutical Industries
Text and Data Mining valid from 2020-04-24
Version of Record valid from 2020-04-24
Article History
Received: 26 February 2020
First Online: 24 April 2020